 CHARLOTTESVILLE, Va., May 18, 2021 GLOBE NEWSWIRE -- Adial Pharmaceuticals, Inc. NASDAQ: ADIL; ADILW Adial, a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today announced that William Stilley, Chief Executive Officer, and Dr. Bankole Johnson, Chief Medical Officer, have been featured on multiple news broadcasts nationwide regarding the Second Pandemic of Addiction arising from the COVID-19 pandemic. 